Related Experiment Video

Updated: Jun 6, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes

Saba Khaliq1, Shah Jahan, Bushra Ijaz

  • 1Applied and Functional Genomics Laboratory, National Centre of Excellence in Molecular Biology, University of Punjab, Lahore 53700, Pakistan.

Archives of Virology
|December 17, 2010
PubMed

Insights

Small interfering RNAs (siRNAs) effectively silenced Hepatitis C virus (HCV) genotype 3a by targeting E1 and E2 genes. This RNA interference approach significantly reduced viral RNA and protein, showing promise for new HCV therapies.

Area of Science:

  • Molecular biology
  • Virology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) genotype 3a is a primary cause of liver disease and cancer in Pakistan.
  • Current therapies for HCV have limited efficacy, necessitating novel treatment strategies.
  • HCV envelope genes E1 and E2 are crucial for viral entry and represent potential therapeutic targets.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) using small interfering RNAs (siRNAs) against HCV genotype 3a.
  • To assess the potential of targeting HCV E1 and E2 genes for therapeutic development.

Main Methods:

  • Gene-specific siRNAs were designed to target the E1 and E2 genes of HCV genotype 3a.
  • siRNA efficacy was evaluated by measuring mRNA and protein levels of E1 and E2 in transfected cells.
  • HCV replication was assessed in serum-infected Huh-7 cells treated with combined siRNAs targeting E1 and E2.

Main Results:

  • Gene silencing using siRNAs significantly reduced both E1 and E2 mRNA and protein expression.
  • Combined siRNA treatment targeting E1 and E2 genes markedly decreased HCV viral copy number in infected cells.
  • RNAi-mediated silencing of E1 and E2 demonstrated potent inhibition of HCV-3a replication.

Conclusions:

  • RNA interference targeting HCV E1 and E2 genes is a viable strategy for reducing viral load.
  • siRNA-based therapy holds significant potential as an alternative treatment for Hepatitis C virus genotype 3a.
  • This study presents one of the first demonstrations of effective RNAi-mediated silencing of HCV E1 and E2 genes.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...